Pearson, Ackman appeal to shareholders after Allergan rejects Valeant's $47B offer

Save

Valeant CEO J. Michael Pearson, a serial acquirer, knows how to play the M&A game. After Allergan earlier this week officially spurned his company's $47 billion offer, he and partner Bill Ackman were ready with their next moves.